FrancophonIA/ELRC3.0 huggingface dataset:
English: In the presence of carbidopa, the apparent terminal elimination half-life (t1/2) of levodopa following a single administration of Inbrija 66 mg (2 x 33 mg capsules) was 2.3 hours and comparable to that following an oral dose of carbidopa/levodopa 25 mg/100 mg immediate release tablets of 1.9 hours.
Maltese: Fil-preżenza ta' carbidopa, il-half-life terminali apparenti tal-eliminazzjoni (t1/2) ta' levodopa wara għoti wieħed ta' Inbrija 66 mg (2 x 33 mg kapsuli) kien 2.3 sigħat u kumparabbli ma' dik wara doża orali ta' pilloli ta' carbidopa/levodopa 25 mg/100 mg li jerħu l-mediċina b'mod immedjat ta' 1.9 sigħat.
English: b A responder was defined as a subject that changed from OFF to ON within 60 minutes post dose and who remained ON at 60 minutes post dose.
Maltese: b Rispondent kien definit bħala individwu li nbidel minn OFF għal ON fi żmien 60 minuta wara d doża u li baqa' ON għal 60 minuta wara d-doża.
English: Take your dose
Maltese: DATA TA' SKADENZA
English: Abdominal pain, Constipation, Diarrhoea,
Maltese: Uġigħ addominali, Stitikezza, Dijarea,
English: Each carton includes blisters of 4 capsules.
Maltese: Kull kartuna tinkludi folji ta' 4 kapsuli.
English: Antihypertensives
Maltese: Hypromellose
English: Patients should be regularly monitored for the development of impulse control disorders.
Maltese: Il-pazjenti għandhom jiġu mmonitorjati regolarment għall-iżvilupp ta' disturbi fil-kontroll tal-impuls.
English: In a subpopulation of the 12-week study, serial spirometry measurements were performed at 15, 30 and 60 minutes following the first dose of Inbrija 66 mg or placebo.
Maltese: F'subpopolazzjoni tal-istudju ta' 12-il ġimgħa, kejl tal-ispettrometrija serjali twettaq fil-15, 30 u 60 minuta wara l-ewwel doża ta' Inbrija 66 mg jew plaċebo.
English: Urinary retention, Chromaturia, Urinary incontinence
Maltese: Inkontinenza urinarja,
English: Musculoskeletal and connective tissue disorders
Maltese: Disturbi muskoluskeletriċi u tat tessuti konnettivi
English: Alignment Arrows
Maltese: TAGĦRIF
English: This punctures the capsule.
Maltese: Armiha u ġib kapsula ġdida.
English: Patients with a major psychotic disorder or a history of psychotic disorder must be treated cautiously with a levodopa/dopa-decarboxylase inhibitor because of the risk of exacerbating psychosis.
Maltese: Pazjenti b'disturb psikotiku maġġuri jew storja ta' disturbi psikotiċi għandhom jiġu ttrattati b'attenzjoni b'inibitur ta' levodopa/dopa-decarboxylase minħabba r-riskju li tiġi aggravata l-psikosi.
English: Interactions of Inbrija with local or systemic pulmonary medicinal products were not investigated because Inbrija is not recommended in patients with asthma, chronic obstructive pulmonary disease (COPD), or other chronic underlying lung disease (see section 4.4).
Maltese: L-interazzjonijiet ta' Inbrija ma' prodotti mediċinali pulmonari lokali jew sistemiċi ma ġewx investigati għaliex Inbrija mhuwiex rakkomandat f'pazjenti bl-ażżma, b'mard kroniku ta' imblukkar fil-pulmun (COPD, chronic obstructive pulmonary disease), jew mard tal-pulmun sottostanti ieħor (ara sezzjoni 4.4).
English: The hard capsules are supplied in Aluminium / PVC / Aluminium peel-off blisters.
Maltese: In-natura tal-kontenitur u ta' dak li hemm ġo fih Il-kapsuli ibsin huma fornuti f'folji li jitqaxxru tal-Aluminium / PVC / Aluminium.
English: The median time to maximal plasma concentration of levodopa was 30 minutes after a dose of Inbrija 66 mg (2 x 33 mg capsules) compared to 45 minutes after a dose of carbidopa/levodopa 25 mg/100 mg immediate release tablets.
Maltese: Il-ħin medjan għall-konċentrazzjoni massima fil-plażma ta' levodopa kien 30 minuta wara doża ta' Inbrija 66 mg (2 x 33 mg kapsuli) mqabbel ma' 45 minuta wara doża ta' carbidopa/levodopa 25 mg/100 mg pilloli li jerħu l-mediċina b'mod immedjat.
English: Sputum discoloured, Nasal discharge discolouration, Throat irritation
Maltese: Qtugħ ta' nifs, Nifs anormali, Disfonija, Sulluzzu
English: Coughing
Maltese: Treddigħ
English: A full dose is 2 capsules.
Maltese: Doża sħiħa hi ta' 2 kapsuli.
English: The UPDRS part III is designed to assess the severity of the cardinal motor findings (e.g. tremor, rigidity, bradykinesia, postural instability) in patients with Parkinson's disease.
Maltese: III tal-UPDRS hija mfassla biex tivvaluta sseverità tas-sejbiet motorji kardinali (eż. rogħda, riġidità, bradikineżija, instabbiltà fil-qagħda) f'pazjenti bil-marda ta' Parkinson.
English: Inhalation powder, hard capsules 60 hard capsules + 1 inhaler
Maltese: U KONTENUT Trab li jittieħed man-nifs, kapsuli ibsin 60 kapsula iebsa + inalatur wieħed 92 kapsula iebsa + inalatur wieħed
English: A clinical study was performed with Inbrija 66 mg (2 x 33 mg capsules) administered to 56 healthy subjects (31 non-smokers and 25 smokers).
Maltese: Twettaq studju kliniku b'Inbrija 66 mg (2 x 33 mg kapsuli) mogħti lil 56 individwi b'saħħithom (31 ma jpejpux u 25 ipejpu).
English: The maximum daily dose of Inbrija should not exceed 10 capsules (330 mg).
Maltese: Id-doża massima ta' kuljum ta' Inbrija m'għandhiex taqbeż l-10 kapsuli (330 mg).
English: The dose-normalised relative bioavailability of a single 66 mg emitted dose of Inbrija was 88.0% (90% CI: 80.3, 96.4) when compared to a single oral carbidopa/levodopa 25 mg/100 mg dose.
Maltese: Il-bijodisponibbiltà relattiva normalizzata skont id-doża, ta' doża waħda emessa ta' 66 mg ta' Inbrija kienet 88.0% (90% CI: 80.
English: Inbrija 33 mg inhalation powder, hard capsules
Maltese: Inbrija 33 mg trab li jittieħed man-nifs, kapsuli ibsin
English: There is only limited data available in very elderly patients (≥75 years).
Maltese: Hemm biss data limitata disponibbli f'pazjenti anzjani ħafna (≥ 75 sena).
English: These can be symptoms of neuroleptic malignant syndrome (NMS, a rare severe reaction to medicines used to treat disorders of the central nervous system) or rhabdomyolisis (a rare severe muscle disorder).
Maltese: Dawn jistgħu jkunu sintomi ta' sindrome malinn newrolettiku (NMS, neuroleptic malignant syndrome, reazzjoni severa rari għal mediċini użati għat-trattament ta' disturbi tas-sistema nervuża ċentrali) jew rabdomijolożi (disturb tal-muskoli sever rari).
English: - if you have a rare tumour of the adrenal gland called phaeochromocytoma.
Maltese: - jekk għandek tumur rari tal-glandola adrenali msejjaħ fejokromoċitoma.
English: COMT inhibitors
Maltese: Inibituri ta' COMT
English: Inhalation powder, hard capsule.
Maltese: OĦRAJN Tiblax il-kapsuli.
English: Agranulocytosis, Thrombocytopenia, Leukopenia
Maltese: Anemija, Agranuloċitosi Tromboċitopenija
English: After administration of Inbrija the Cmax and AUC0-24 h was 11% to 12% higher for smokers than for non-smokers.
Maltese: Wara l-għoti ta' Inbrija is-Cmax u l-AUC0-24 siegħa kienu bejn 11% u 12% ogħla għal dawk li jpejpu milli għal dawk li ma jpejpux.
English: The maximum dose of Inbrija is 10 capsules per day.
Maltese: Id-doża massima ta' Inbrija hija ta' 10 kapsuli kuljum.
English: A symptom complex resembling neuroleptic malignant syndrome and rhabdomyolysis may occur with levodopa/dopa-decarboxylase inhibitor medicinal products, although no cases have been identified in clinical studies with Inbrija.
Maltese: Kumpless ta' sintomi li jixbah issindrome malinn newrolettiku u rabdomijolożi jista' jseħħ bi prodotti mediċinali ta' inibitur ta' levodopa/dopa-decarboxylase, għalkemm ma ġew identifikati l-ebda każijiet fi studji kliniċi b'Inbrija.
English: Psychotic reactions have been observed in patients receiving amantadine and levodopa.
Maltese: Reazzjonijiet psikotiċi ġew osservati f'pazjenti li ngħataw amantadine u levodopa.
English: Serious adverse reactions of allergic oedema have been reported with levodopa medicinal products but not in clinical studies with Inbrija.
Maltese: Reazzjonijiet avversi serji ta' edema allerġika ġew irrappurtati bi prodotti mediċinali ta' levodopa iżda mhux fi studji kliniċi b'Inbrija.
English: Pathological gambling, increased libido, hypersexuality, compulsive spending or buying, binge eating and compulsive eating can occur in patients treated with dopamine agonists and/or other dopaminergic treatments containing levodopa (see section 4.4).
Maltese: Logħob tal-ażżard patoloġiku, żieda fil-libido, ipersesswalità, infieq jew xiri kompulsiv, li tiekol aktar milli suppost jew li tiekol b'mod kompulsiv jista' jseħħ f'pazjenti kkurati b'agonisti tad-dopamine u/jew trattamenti dopaminerġiċi oħrajn li fihom levodopa (ara sezzjoni 4.4).
English: The safety and efficacy of Inbrija in children under 18 years of age have not been established.
Maltese: Is-sigurtà u l-effikaċja ta' Inbrija fit-tfal ta' inqas minn 18-il sena għadhom ma ġewx determinati.
English: Orthostatic hypotension (see section 4.4),
Maltese: Tentattiv ta' suwiċidju (ara sezzjoni 4.4),
English: Dyspepsia,
Maltese: Aċċessjoni,
English: Baseline Levodopa dose
Maltese: Popolazzjoni pedjatrika
English: The addition of entacapone to a levodopa/dopa-decarboxylase inhibitor has been demonstrated to increase the levodopa bioavailability by 30%.
Maltese: Iż-żieda ta' entacapone ma' inibitur ta' levodopa/dopa-decarboxylsae ntweriet li żżid ilbijodisponibbiltà ta' levodopa bi 30%.
English: Interference with test
Maltese: DATA TA' REVIŻJONI TAT-TEST
English: Concomitant use of antipsychotics should be monitored carefully for worsening of Parkinson's motor symptoms especially when D2-receptor antagonists are used (see section 4.5).
Maltese: L-użu fl-istess ħin ta' antipsikotiċi għandu jiġi mmonitorjat mill-qrib għal aggravar ta' sintomi motorji tal-marda ta' Parkinson speċjalment meta jintużaw antagonisti tar-riċettur D2 (ara sezzjoni 4.5).
English: Caution should be exercised when interpreting the plasma and urine levels of catecholamines and their metabolites in patients on levodopa or levodopa/dopadecarboxylase inhibitor therapy.
Maltese: Għandha tingħata attenzjoni meta jiġu interpretati l-livelli ta' catecholamines u l-metaboliti tagħhom fil-plażma u fl-awrina f'pazjenti fuq terapija b'levodopa jew inibitur ta' levodopa/dopa-decarboxylase.
English: Most cough reported in the clinical studies with Inbrija were mild to moderate in intensity, and usually reported within the first 30 days of the treatment.
Maltese: Sogħla Il-maġġoranza tas-sogħla rrappurtata fi studji kliniċi b'Inbrija kienu minn ħfief sa moderati fl intensità, u normalment kienu rrappurtati fl-ewwel 30 jum tat-trattament.
English: Reduction in mean daily OFF time and improvement on the Patient Global Impression of Change (PGI-C) scale, a patient reported outcome of the overall improvement and satisfaction with Inbrija treatment, and Responders ON were the main secondary endpoints.
Maltese: Tnaqqis fil-ħin OFF medju ta' kuljum u titjib fl-iskala tal-Impressjoni ta' Bidla Globali talPazjent (PGI-C, Patient Global Impression of Change), riżultat irrappurtat mill-pazjent dwar titjib u sodisfazzjon globali bit-trattament b'Inbrija, u Rispondenti ON kienu l-punti tat-tmiem sekondarji ewlenin.
English: Important information before you use Inbrija: - Inbrija capsules must not be swallowed.
Maltese: Informazzjoni importanti qabel tuża Inbrija: - Il-kapsuli ta' Inbrija m'għandhomx jinbelgħu.
English: Muscle spasms, Trismus
Maltese: Dardir, Rimettar
English: Dry mouth,
Maltese: Żamma tal-awrina,
English: Seizure,
Maltese: Parestesija,
English: - The active substance is levodopa.
Maltese: X'fih Inbrija - Is-sustanza attiva hi levodopa.
English: Step 1: Gather supplies
Maltese: Tabella 1: Reazzjonijiet avversi
English: Dispose and store Step 12: Dispose of used capsules
Maltese: Rimi u ħażna It-12-il Pass: Rimi ta' kapsuli użati
English: A clinical study was performed with Inbrija 66 mg (2 x 33 mg capsules) in 24 healthy subjects (13 men and 11 women).
Maltese: Twettaq studju kliniku b'Inbrija 66 mg (2 x 33 mg kapsuli) f'24 voluntiera b'saħħithom (13-il raġel u 11-il mara).
English: Levodopa is a precursor of dopamine, and is given as dopamine replacement therapy in Parkinson's disease.
Maltese: Levodopa huwa prekursur ta' dopamine, u jingħata bħala terapija ta' sostituzzjoni ta' dopamine filmarda ta' Parkinson.
English: You should hear the capsule “whirl”.
Maltese: Uża kapsula waħda għaliha.
English: Ink
Maltese: SN
English: Levodopa has been associated with somnolence and episodes of sudden sleep onset (see section 4.7).
Maltese: Ħedla tan-ngħas u episodji ta' rqad li jiġi f'daqqa Levodopa kien assoċjat ma' ħedla tan-ngħas u episodji ta' rqad li jiġi f'daqqa (ara sezzjoni 4.7).
English: Get inhaler and strip of capsules.
Maltese: Ġib l-inalatur u l-istrixxa tal-kapsuli.
English: Cardiac rhythm disordersa (see section 4.4),
Maltese: Disturb fir-ritmu tal-qalba (ara sezzjoni 4.4),
English: Due to cough, 2% of subjects withdrew from the clinical studies with Inbrija.
Maltese: Minħabba s-sogħla, 2% tal individwi rtiraw mill-istudji kliniċi b'Inbrija.
English: Confusional state, Hallucination,
Maltese: Stat ta' konfużjoni, Alluċinazzjoni, Dipressjoni, Ansjetà,
English: Thrombophlebitis, Hot flush
Maltese: Sinkope, Tromboflebite,
English: Inbrija inhalation powder, hard capsules consist of a white powder for inhalation filled into white opaque hard capsules with “A42” printed in black on the cap of the caspule and two black bands printed on the body of the capsule.
Maltese: Kapsuli opaki ta' lewn abjad li fihom trab abjad, b'“A42” stampata bl-iswed fuq l-għatu tal-kapsula u żewġ faxex suwed stampati fuq il-bqija tal-kapsula.
English: The effect of Inbrija on pulmonary function was also evaluated in patients with Parkinson's disease treated with an oral levodopa/dopa-decarboxylase inhibitor in a 12-month, randomised, controlled, open-labeled study.
Maltese: L-effett ta' Inbrija fuq il-funzjoni pulmonari kien evalwat ukoll f'pazjenti bil-marda ta' Parkinson ittrattati b'inibitur orali ta' levodopa/dopa-decarboxylase mill-ħalq fi studju ta' 12-il xahar fejn ilpazjenti ntgħażlu b'mod każwali, ikkontrollat u open label.
English: Instructions for use:
Maltese: Istruzzjonijiet għall- użu:
English: Common (may affect up to 1 in 10 people): - new or increased abnormal body movements (dyskinesia); - infections of nose, sinuses, throat or lungs; - change in colour of your mucus; - discoloured (i.e. not clear) nasal mucus; - irritation in throat or itchy throat; - feeling sick (nausea); vomiting; - being prone to falls.
Maltese: Komuni (jistgħu jaffettwaw sa 1 minn kull 10 persuni): - movimenti tal-ġisem anormali ġodda jew miżjuda (diskineżija); - infezzjonijiet tal-imnieħer, tas-sinuses, tal-gerżuma jew tal-pulmun; - tibdil fil-kulur tal-muku tiegħek; - kulur anormali (jiġifieri mhux trasparenti) tal-muku tal-imnieħer; - irritazzjoni fil-gerżuma jew ħakk fil-gerżuma; - tħossok ma tiflaħx (dardir); rimettar; - tkun suxxettibbli għal waqgħat.
English: Pulmonary function was assessed by spirometry and carbon monoxide diffusing capacity (DLCO) every 3 months in both groups.
Maltese: Ilfunzjoni pulmonari kienet ivvalutata bl-ispettrometrija u bil-kapaċità tad-diffużjoni tal-monossidu talkarbonju (DLCO) kull 3 xhur fiż-żewġ gruppi.
English: Levodopa is associated with somnolence and has been associated very rarely with excessive daytime somnolence and sudden sleep onset episodes.
Maltese: Levodopa hu assoċjat man-ngħas u kien assoċjat b'mod rari ħafna ma' ngħas eċċessiv matul il-jum u episodji ta' rqad li jiġi f'daqqa.
English: Neoplasm benign, malignant and unspecified (incl.
Maltese: Neoplażmi beninni, malinni u dawk mhux speċifikati (inklużi ċesti u polipi)
English: Dyspnoea,
Maltese: Distonja,
English: Do not use Inbrija if you have taken medicines called non-selective MAO inhibitors for treating depression in the last 14 days.
Maltese: Tużax Inbrija jekk ħadt mediċini msejħa inibituri mhux selettivi ta' MAO għat-trattament ta' dipressjoni fl-aħħar 14-il jum.
English: Glaucoma
Maltese: Lewkopenija
English: The effectiveness of Inbrija for the treatment of OFF episodes in patients with Parkinson's disease given on top of background dopaminergic treatment was evaluated in a 12-week, randomised, placebo-controlled, double-blind study.
Maltese: L-effettività ta' Inbrija għat-trattament ta' episodji OFF f'pazjenti bil-marda ta' Parkinson mogħtija flimkien ma' trattament dopaminerġiku fl-isfond kienet evalwata fi studju ta' 12-il ġimgħa, fejn ilpazjenti ntgħażlu b'mod każwali, ikkontrollat bi plaċebo, double-blind.
English: Dyskinesia
Maltese: Prijapiżmu
English: Using more than one dose of Inbrija (2 capsules) to treat the same OFF period may result in CNS disturbances, with an increasing likelihood of cardiovascular disturbance (e.g. hypotension, tachycardia) and more severe psychiatric problems at higher doses.
Maltese: Jekk tuża aktar minn doża waħda ta' Inbrija (2 kapsuli) biex tittratta l-istess perjodu OFF, dan jista' jirriżulta f'disturbi tas-CNS, b'żieda fil-probabbiltà ta' disturb kardjovaskulari (eż. pressjoni baxxa, takikardija) u problemi psikjatriċi aktar severi f'dożi ogħla.
English: Adverse reactions are presented by system organ class and frequency in Table 1 below.
Maltese: Ir-reazzjonijiet avversi huma elenkati hawn taħt f'Tabella 1 skont is-sistema tal-klassifika tal-organi u skont il-frekwenza.
English: The use of selective MAO-B inhibitors (e.g. rasagiline, selegiline, and safinamide) with levodopa may be associated with orthostatic hypotension.
Maltese: L-użu ta' inibituri selettivi ta' MAO-B (eż. rasagiline, selegiline, u safinamide) ma' levodopa jista' jkun assoċjat ma' pressjoni baxxa ortostatika.
English: Glossodynia,
Maltese: Sturdament,
English: After correcting the parameters for body weight, the gender difference after each treatment was no longer significant: the body-weight adjusted Cmax and AUC0-24 h after a dose of Inbrija in women were 9.7% and 15.1% higher than men.
Maltese: Wara li ġew ikkoreġuti l-parametri għall-piż tal-ġisem, id-differenza fil-ġeneru wara kull trattament ma kinitx aktar sinifikanti: is-Cmax u l-AUC0-24 siegħa aġġustati għall-piż tal-ġisem wara doża ta' Inbrija fin-nisa kienu 9.7% u 15.
English: Patients being treated with levodopa medicinal products and presenting with somnolence and/or sudden sleep episodes must be informed to refrain from driving or engaging in activities where impaired alertness may put themselves or others at risk of serious injury or death (e.g. use machines), until such recurrent episodes and somnolence have resolved (see also section 4.4).
Maltese: Pazjenti li qed jiġu kkurati b'prodotti mediċinali ta' levodopa u li jkollhom ħedla tan-ngħas u/jew episodji ta' rqad li jiġi f'daqqa għandhom ikunu infurmati biex ma jsuqux u ma jagħmlux attivitajiet fejn in-nuqqas ta' attenzjoni jista' jpoġġi lilhom jew lill-oħrajn f'riskju ta' korriment serju jew mewt (eż. jħaddmu l-magni), sakemm dawn l-episodji rikorrenti u l-ħedla tan-ngħas ikunu ġew ikkurati (ara wkoll sezzjoni 4.4).
English: Somnolence and episodes of sudden sleep onset
Maltese: Korriment, avvelenament u komplikazzjonijiet ta' xi proċedura
English: Other side effects you may experience of which the frequency is not known include:
Maltese: Effetti sekondarji oħra li jista' jkollok li l-frekwenza tagħhom mhix magħrufa jinkludu:
English: risperidone, chlorpromazine, fluphenazine decanoate, phenotiazine, butyrophenone, or trifluoperazine; - metoclopramide to treat nausea; - isoniazid, an antibiotic to treat tuberculosis; - medicines for high blood pressure, as the dose may need to be adjusted; - medicines for depression called tricyclic antidepressants such as clomipramin, desipramin, or doxepin; - amantadine to treat flu or your Parkinson's disease.
Maltese: Għid lit-tabib jew lill-ispiżjar tiegħek jekk qed tieħu: - mediċini għat-trattament tal-marda ta' Parkinson tiegħek imsejħa inibituri selettivi ta' MAO bħal rasagiline, selegiline u safinamide, inibituri ta' COMT bħal entacapone, tolcapone u opicapone, jew antikolinerġiċi bħal orphenadrine u trihexyphenidyl; - mediċini għal kundizzjonijiet mentali inkluż skizofrenija, bħal benperidol, haloperidol, risperidone, chlorpromazine, fluphenazine decanoate, phenotiazine, butyrophenone, jew trifluoperazine; - metoclopramide għat-trattament ta' dardir; - isoniazid, antibijotiku użat għat-trattament tat-tuberkulożi; - mediċini għat-trattament tal-pressjoni tad-demm għolja, għax id-doża jista' jkun li tkun trid tiġi aġġustata; - mediċini għat-trattament ta' dipressjoni msejħa antidipressanti triċikliċi bħal clomipramine, desipramine, jew doxepin; - amantadine għat-trattament ta' influwenza jew tal-marda ta' Parkinson tiegħek.
English: Step 6: Attach white mouthpiece Align arrows on mouthpiece and handle
Maltese: Id-9 Pass: Żomm in-nifs għal 5 sekondi, imbagħad itilqu
English: Table 2: Baseline features and results of the efficacy endpoints Parameters
Maltese: Tabella 2: Karatteristiċi tal-linja bażi u riżultati tal-punti tat-tmiem tal-effikaċja
English: Sudden sleep onset
Maltese: Twissijiet u prekawzjonijiet
English: The recommended dose of Inbrija is 2 hard capsules up to 5 times per day each delivering 33 mg levodopa.
Maltese: Id-doża rakkomandata ta' Inbrija hija ta' 2 kapsuli ibsin sa 5 darbiet kuljum li kull waħda tagħti 33 mg ta' levodopa.
English: Levodopa should be administered cautiously to patients with a history of peptic ulcer disease (because of the possibility of upper gastro-intestinal haemorrhage).
Maltese: - jekk qed tieħu ċerti mediċini kontra d-dipressjoni msejħa inibituri mhux selettivi ta' MAO (eż. isocarboxazid u phenelzine).
English: • A complete dose is 2 capsules used one after the other.
Maltese: • Doża kompleta hija 2 kapsuli użati waħda wara l-oħra.
English: After 12 months, the average reduction in FEV1 from baseline was the same in both groups (-0.1 L).
Maltese: Wara 12-il xahar, it-tnaqqis medju fil-FEV1 mil-linja bażi kien l-istess fiż-żewġ gruppi (-0.1 L).
English: Animal studies indicated no effect on fertility (see section 5.3).
Maltese: Studji f'annimali ma indikaw l-ebda effett fuq il-fertilità (ara sezzjoni 5.3).
English: Blood lactate dehydrogenase increased,
Maltese: Sindrome tas-saqajn bla kwiet,
English: A total of 114 patients were randomised and treated with Inbrija 66 mg (two 33 mg capsules) and 112 patients received placebo.
Maltese: Total ta' 114-il pazjent intgħażlu b'mod każwali u ġew trattati b'Inbrija 66 mg (żewġ kapsuli ta'
English: These may be symptoms of “withdrawal-emergent hyperpyrexia”.
Maltese: Dawn jistgħu jkunu sintomi ta' “iperpiressja li tirriżulta mill-waqfien”.
English: Each delivered dose contains 33 mg levodopa.
Maltese: Kull doża mogħtija fiha 33 mg ta' levodopa.
English: The use of Inbrija is not recommended in patients under 18 years of age.
Maltese: Tfal u adolexxenti L-użu ta' Inbrija mhuwiex rakkomandat f'pazjenti ta' inqas minn 18-il sena.
English: - medicines for your Parkinson's disease called selective MAO inhibitors such as rasagiline, selegiline and safinamide, COMT inhibitors such as entacapone, tolcapone and opicapone, or anticholinergics such as orphenadrine and trihexyphenidyl;
Maltese: L-għoti fl-istess ħin ta' levodopa u amantadine jista' jżid il-konfużjoni, l-alluċinazzjonijiet, il-ħolm ikrah, id-disturbi gastro-intestinali, jew effetti sekondarji oħra bħal ta' atropine.
English: Tear off package of 2 capsules.
Maltese: Aqta' parti b'2 kapsuli.
English: Attach mouthpiece
Maltese: .8 Effetti mhux mixtieqa